
Chemotherapy is an integral part of treatment for patients with nasopharyngeal carcinoma. Chemotherapy can achieve long-term survival rates of up to 15% to 20%, even in patients with recurrent or metastatic disease. In
Your AI-Trained Oncology Knowledge Connection!
Published: August 1st 2000 | Updated: